...
首页> 外文期刊>Translational research: the journal of laboratory and clinical medicine >Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells.
【24h】

Prevention of allograft rejection by amplification of Foxp3(+)CD4(+)CD25(+) regulatory T cells.

机译:通过扩增Foxp3(+)CD4(+)CD25(+)调节性T细胞来防止同种异体移植排斥。

获取原文
获取原文并翻译 | 示例
           

摘要

CD4(+)CD25(+) T cells were identified originally as potent suppressors of autoimmunity and were later termed "natural regulatory T cells" or nTreg cells. Subsequently, a transcription factor called forkhead box protein 3 (Foxp3) was identified to be a critical regulator for Treg differentiation and function. Foxp3(+)CD4(+)CD25(+) Treg cells have been increasingly documented to suppress allograft rejection and to mediate allograft tolerance in transplantation. In this article, the authors review current approaches for amplification of allo-specific Foxp3(+)CD4(+)CD25(+) Treg cells for prevention of allograft rejection and induction of allo-specific transplant tolerance.
机译:CD4(+)CD25(+)T细胞最初被鉴定为有效的自身免疫抑制剂,后来被称为“天然调节性T细胞”或nTreg细胞。随后,一种称为叉头盒蛋白3(Foxp3)的转录因子被鉴定为Treg分化和功能的关键调节因子。 Foxp3(+)CD4(+)CD25(+)Treg细胞已被越来越多地证明可抑制同种异体移植排斥并介导同种异体移植的耐受性。在本文中,作者回顾了目前用于扩增同种异体特异性Foxp3(+)CD4(+)CD25(+)Treg细胞的方法,以防止同种异体移植排斥和诱导同种异体移植耐受性。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号